103
IRUS TotalDownloads
Altmetric
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.
File | Description | Size | Format | |
---|---|---|---|---|
eabf3698.full.pdf | Published version | 2.04 MB | Adobe PDF | View/Open |
Title: | Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection. |
Authors: | Reynolds, CJ Swadling, L Gibbons, JM Pade, C Jensen, MP Diniz, MO Schmidt, NM Butler, DK Amin, OE Bailey, SNL Murray, SM Pieper, FP Taylor, S Jones, J Jones, M Lee, W-YJ Rosenheim, J Chandran, A Joy, G Di Genova, C Temperton, N Lambourne, J Cutino-Moguel, T Andiapen, M Fontana, M Smit, A Semper, A O'Brien, B Chain, B Brooks, T Manisty, C Treibel, T Moon, JC COVIDsortium investigators Noursadeghi, M COVIDsortium immune correlates network Altmann, DM Maini, MK McKnight, Á Boyton, RJ |
Item Type: | Journal Article |
Abstract: | Understanding the nature of immunity following mild/asymptomatic infection with SARS-CoV-2 is crucial to controlling the pandemic. We analyzed T cell and neutralizing antibody responses in 136 healthcare workers (HCW) 16-18 weeks after United Kingdom lockdown, 76 of whom had mild/asymptomatic SARS-CoV-2 infection captured by serial sampling. Neutralizing antibodies (nAb) were present in 89% of previously infected HCW. T cell responses tended to be lower following asymptomatic infection than in those reporting case-definition symptoms of COVID-19, while nAb titers were maintained irrespective of symptoms. T cell and antibody responses were sometimes discordant. Eleven percent lacked nAb and had undetectable T cell responses to spike protein but had T cells reactive with other SARS-CoV-2 antigens. Our findings suggest that the majority of individuals with mild or asymptomatic SARS-CoV-2 infection carry nAb complemented by multispecific T cell responses at 16-18 weeks after mild or asymptomatic SARS-CoV-2 infection. |
Issue Date: | 23-Dec-2020 |
Date of Acceptance: | 18-Dec-2020 |
URI: | http://hdl.handle.net/10044/1/86000 |
DOI: | 10.1126/sciimmunol.abf3698 |
ISSN: | 2470-9468 |
Publisher: | American Association for the Advancement of Science |
Start Page: | 1 |
End Page: | 19 |
Journal / Book Title: | Science Immunology |
Volume: | 5 |
Issue: | 54 |
Copyright Statement: | © 2020, American Association for the Advancement of Science https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
Keywords: | Antibodies, Neutralizing Antibodies, Viral Asymptomatic Infections COVID-19 Case-Control Studies Cross-Sectional Studies Humans SARS-CoV-2 T-Lymphocytes Antibodies, Neutralizing Antibodies, Viral Asymptomatic Infections COVID-19 Case-Control Studies Cross-Sectional Studies Humans SARS-CoV-2 T-Lymphocytes COVIDsortium investigators COVIDsortium immune correlates network T-Lymphocytes Humans Antibodies, Viral Case-Control Studies Cross-Sectional Studies Antibodies, Neutralizing Asymptomatic Infections COVID-19 SARS-CoV-2 |
Publication Status: | Published |
Conference Place: | United States |
Online Publication Date: | 2020-12-23 |
Appears in Collections: | Department of Immunology and Inflammation Department of Infectious Diseases Imperial College London COVID-19 |
This item is licensed under a Creative Commons License